Skip to main content
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Reuters Health Features New England Journal of Medicine Study Co-Led by Dr. Gerard Criner

View All News

Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, was corresponding author on a study published online in the New England Journal of Medicine which shows that the asthma drug benralizumab failed to decrease annual COPD exacerbation rates for patients with moderate to very severe COPD, a history of frequent moderate and/or severe exacerbations, and eosinophilic inflammation. Dr. Criner provided comments to Reuters Health about the study findings, and MD Alert picked up the piece.